search Menü
Suche

October 2022: New cervical screening test could predict cell changes years before they happen

A new publication from Professor Martin Widschwendter and the EUTOPS team in Genome Medicine describes a new molecular "WID®-CIN test" that can identify 55% of those with a normal cervical smear result who will go on to develop advanced cell changes or cancer within 4 years. The new test is part of a research program that aims to predict the risk of four cancers (breast, ovarian, womb and cervical) from a single cervical smear.

Find a video outlining the principle of the test below, or read the research:

The WID‑CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer

Barrett, Sundström, Jones et al, Genome Medicine, 2022

Read more

EUTOPS Institute

Our vision is to integrate cutting-edge research in systems biology and oncology to enable real-world implementation of the concepts of P4 medicine (predictive, preventive, personalised and participatory) and drastically reduce cancer mortality.

Meet the Team

We are a dynamic and international team with wide range of expertise.